◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 3151

Vital KSK Holdings, Inc. (3151) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Distribution · DATA UPDATED 2026-08-10

Vital KSK Holdings, Inc. (3151) operates in the Medical Distribution industry and is headquartered in Setagaya, Japan with about 3,871 employees. Its market capitalization is roughly JPY 77 billion. In the fiscal year ended 2026-03-31, 3151 reported JPY 610.5B in revenue and JPY 7.4B in net income.

Vital KSK Holdings, Inc. engages in the wholesale and retail sale of pharmaceutical products in Japan.

Interactive charts & full statements →

3151 Revenue & Earnings History — Annual Income Statement

Income statement2026-03-312025-03-312024-03-312023-03-31
Total RevenueJPY 610.5BJPY 600.4BJPY 587.5BJPY 581.3B
Gross ProfitJPY 49.6BJPY 49.2BJPY 48.3BJPY 46.5B
Operating Income (EBIT)JPY 4.0BJPY 5.7BJPY 5.6BJPY 4.0B
Net IncomeJPY 7.4BJPY 7.3BJPY 5.8BJPY 4.8B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

3151 Free Cash Flow History

Cash flow2026-03-312025-03-312024-03-312023-03-312022-03-31
Dividends Paid(JPY 2.8B)(JPY 2.2B)(JPY 2.4B)(JPY 1.4B)

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

3151 Balance Sheet History

Balance sheet2026-03-312025-03-312024-03-312023-03-31
Total AssetsJPY 320.6BJPY 299.4BJPY 317.3BJPY 297.3B
Total LiabilitiesJPY 201.9BJPY 192.1BJPY 211.3BJPY 197.2B

JPY; JPYM / JPYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 3151 viewer.

Other Companies in Medical Distribution

← 3150All “0-9” companies3153 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.